Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better

OBJECTIVE: To assess outcomes in treatment-naive eyes with neovascular age-related macular degeneration (nAMD) and good baseline visual acuity (VA) treated using a treat-and-extend (T&E) regimen with intravitreal aflibercept, ranibizumab, or bevacizumab. DESIGN: Single center, retrospective, obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanani, Arshad M, Gahn, Greggory M, Koci, Micaela M, Dang, Jonathan M, Brown, Sandra M, Hill, Lauren F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387604/
https://www.ncbi.nlm.nih.gov/pubmed/30858684
http://dx.doi.org/10.2147/OPTH.S191170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387604/
https://www.ncbi.nlm.nih.gov/pubmed/30858684
http://dx.doi.org/10.2147/OPTH.S191170

Ejemplares similares